Synthesis and Biological Evaluation of 4-Aminoantipyrine Analogues

Med Chem. 2022;18(1):26-35. doi: 10.2174/1573406416666201106105303.

Abstract

Objectives: The aim of the present study is to carry out a simple synthesis of aminoantipyrine analogues and exploration of their antibacterial, cytotoxic, and anticonvulsant potential.

Methods: The compounds were characterized employing multi-spectroscopic methods. The in vitro pharmacological response of a series of bacteria was screened employing serial dilution method. The derivatives were screened against maximal electro-shock for their anticonvulsant activity. Molecular docking was carried out to optimize the interaction of the compounds with HPV16-E7 receptors. Further, the in vitro cytotoxicity was tested against human cervical cancer (SiHa) cell lines.

Results: The compounds show protection against maximal electroshock, esp. 3-nirto- and 4- methyl-3-nitrobenzamido derivatives. In addition, they reveal appreciable DNA cleavage activities and interactions with HPV16-E7 protein receptors, esp. 3,5-dinitro- and 4-methyl-3-nitrobenzamido derivatives. Furthermore, they show potent activity against cervical cancer cells (LD50 value up to 1200 in the case of 4-methyl-3-nitrobenzamido derivative and an inhibition of a maximum of ~97% of cells).

Conclusion: The simply synthesized aminoantipyrine derivatives show a variety of biological activities like antibacterial and anticancer effects. In addition, this is the first study demonstrating that 4-aminoantipyrine derivatives show an anticonvulsant activity.

Keywords: 4-Aminoantipyridine; antibacterial; anticonvulsant; cytotoxicity; molecular docking.; spectroscopy.

MeSH terms

  • Ampyrone* / toxicity
  • Anticonvulsants / therapeutic use
  • Anticonvulsants / toxicity
  • Antineoplastic Agents* / pharmacology
  • Humans
  • Molecular Docking Simulation
  • Structure-Activity Relationship

Substances

  • Anticonvulsants
  • Antineoplastic Agents
  • Ampyrone